495. De novo emergence of resistance mutations during treatment of SARSCoV-2 infection in immunocompromised patients

BACKGROUND: Vaccination and therapeutic strategies for COVID-19 are constantly hindered by the rapid emergence of new viral variants less sensitive to antibodies or antivirals. Emerging evidence points to prolonged replication in the immunocompromised host as a key factor contributing to emergence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Katherine, Soave, Rosemary, Wang, Wei, Albert, Joshua, Kodiyanplakkal, Rosy Priya, Salpietro, Maria, Jing-Mei, Hsu, Diel, Diego G, Ghedin, Elodie, Salvatore, Mirella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679207/
http://dx.doi.org/10.1093/ofid/ofad500.564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679207/
http://dx.doi.org/10.1093/ofid/ofad500.564

Ejemplares similares